BBC
Virtus LifeSci Biotech Clinical
BBC
26,17
0,01 Bil. AUM
0,8% Expense Ratio
25,81 NAV
Virtus LifeSci Biotech Clinical Profile
About Virtus LifeSci Biotech Clinical
Under normal market conditions, the fund will invest not less than 80% of its assets in component securities of the index. The index seeks to track the performance of the common stock of U.S. exchange-listed biotechnology companies with a primary product offering ("lead drug") that is typically in a Phase 1, Phase 2 or Phase 3 clinical trial stage of development, but prior to receiving marketing approval.
- Company
- Holdings
- 198
- CUSIP
- 26923G301
Virtus LifeSci Biotech Clinical Sectors
| Industry | Percentage |
|---|---|
| Healthcare | 100,00% |
| Basic Materials | 0,00% |
| Technology | 0,00% |
| Real Estate | 0,00% |
| Industrials | 0,00% |
| Financial Servic | 0,00% |
| Energy | 0,00% |
| Consumer Defensi | 0,00% |
| Consumer Cyclica | 0,00% |
| Communication Se | 0,00% |
| Utilities | 0,00% |